Cover Image
市場調查報告書

中國的體外診斷(IVD)市場:預測、企業分析

China In Vitro Diagnostics (IVD) Market, Forecast & Companies Analysis

出版商 Renub Research 商品編碼 320308
出版日期 內容資訊 英文 77 Pages; 34 Figures
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的體外診斷(IVD)市場:預測、企業分析 China In Vitro Diagnostics (IVD) Market, Forecast & Companies Analysis
出版日期: 2014年12月02日 內容資訊: 英文 77 Pages; 34 Figures
簡介

中國的體外診斷(IVD)市場規模,預計至2018年以金額為準比2013年的市場規模擴大2倍以上。各市場區隔中,免疫檢測市場構成最大的市場佔有率。臨床化學為第2名,市場佔有率雖然年年減少,但是市場年年擴大。分子診斷為第3名,市場佔有率年年擴大。各企業中Roche構成最大的市場佔有率。

本報告提供中國的體外診斷(IVD)市場相關調查、市場規模與預測、各市場區隔的市場與預測、發展環境和法規情形,及各企業的IVD銷售額與預測等彙整資料,為您概述為以下內容。

第1章 摘要整理

第2章 中國的IVD市場、市場佔有率

  • 中國的IVD市場
  • 中國的IVD市場佔有率
  • 中國的IVD市場企業的佔有率

第3章 中國的IVD市場:各市場區隔

  • 中國的臨床化學市場
  • 中國的免疫檢測法市場
  • 中國的血液學市場
  • 中國的凝固市場
  • 中國的微生物學市場
  • 中國的分子檢驗市場
  • 中國的血糖自我監測(SMBG)市場
  • 中國的照護現場檢驗(POCT)市場

第4章 中國的IVD產業的發展環境

  • 醫療改革狀況
  • 國民利益政策狀況
  • 醫院升級的必要條件

第5章 體外診斷劑登記管理簡介

  • 中國的IVD市場上法規的歷史
  • 中國的IVD市場上法規情形
  • 中國的IVD市場上法規趨勢

第6章 中國的IVD產業促進要素

  • 為了限制實驗室檢驗的政府配合措施
  • 民間醫院、獨立檢驗實驗室數的增加

第7章 中國IVD產業上的課題

  • 當地企業的先進技術專門知識的不足
  • 在中國的IVD市場中的價格壓力抑制跨國IVD企業的參加
  • 各產品的醫療費償付率依據各地區而異

第8章 中國的IVD市場:各企業的銷售額分析

  • Roche Diagnostic:中國的IVD銷售額與預測
  • Sysmex Corporation:中國的IVD銷售額與預測
  • Mindray Medical International Limited:中國的IVD銷售額與預測
  • Shanghai Kehua Bio-Engineering Co. Ltd.:中國的IVD銷售額與預測
  • 其他:中國的IVD銷售額與預測

第9章 主要民間臨床實驗室及診斷服務企業簡介

  • Zhejiang Di'an Diagnostics Technology Co., Ltd.
    • 企業概要
    • 提供產品與服務
  • ADICON Clinical Laboratories (Privately held)
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global (Privately held)
  • BGI-Shenzhen
  • OriGene Technologies

圖表清單

目錄

China is gradually becoming a competitive force and evolving into the world's fastest growing market for In Vitro Diagnostics (IVD) products. By 2018 Chinese IVD market with Billion US$ is expected to be twice more than from its current market size in 2013. Immunoassay has the highest market share compared to all other segments of In Vitro Diagnostics. Clinical Chemistry is in the 2nd position, but its market share is declining year on year, however its market is growing year on year. Molecular Diagnostics holds the 3rd position and its market share is also rising year on year. Roche holds the highest market share in China In Vitro Diagnostics market.

This is 3rd edition report on In Vitro Diagnostics sector by Renub Research . Report titled "China In Vitro Diagnostics (IVD) Market, Forecast & Companies Analysis " provides a comprehensive assessment of the fast-evolving, high-growth IVD Market in China. This 77 page report with 34 Figures studies the China IVD market from 4 view points :

  • 1) Market and Forecast
  • 2) Segment Wise Market & Forecast
  • 3) Development Environment & Regulatory Status in China IVD market
  • 4) Company Wise IVD Sales & Forecast

China IVD Market - Application Segment Analysis (2007 - 2018)

  • Clinical Chemistry Market
  • Immunoassay Market
  • Hematology Market
  • Coagulation Market
  • Microbiology Market
  • Molecular Testing Market
  • Self Monitoring of Blood Glucose (SMBG) Market
  • Point of Care Testing (POCT) Market

China IVD - Company Wise Sales Analysis (2010 - 2018)

  • Roche Diagnostic
  • Sysmex Corporation
  • Mindray Medical International Limited
  • Shanghai Kehua Bio-Engineering Co. Ltd.
  • Others

Profiles of Private Clinical Labs and Diagnostic Services Companies in China

  • Zhejiang Di'an Diagnostics Technology Co., Ltd
  • ADICON Clinical Laboratories
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global (Privately held)
  • BGI-Shenzhen (Privately held)
  • OriGene Technologies (Privately held)

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephonic interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Table of Contents

1. Executive Summary

2. China IVD Market & Market Share (2007 - 2018)

  • 2.1 China IVD Market (2007 - 2018)
  • 2.2 China IVD Market Share (2007 - 2018)
  • 2.3 China IVD Market Players Share (2010 - 2018)

3. China IVD Market by Segments (2007 - 2018)

  • 3.1 China Clinical Chemistry Market (2007 - 2018)
  • 3.2 China Immunoassay Market (2007 - 2018)
  • 3.3 China Hematology Market (2007 - 2018)
  • 3.4 China Coagulation Market (2007 - 2018)
  • 3.5 China Microbiology Market (2007 - 2018)
  • 3.6 China Molecular Testing Market (2007 - 2018)
  • 3.7 China Self Monitoring of Blood Glucose (SMBG) Market (2007 - 2018)
  • 3.8 China Point of Care Testing (POCT) Market (2007 - 2018)

4. Development Environment of Chinese IVD Industry

  • 4.1 State Healthcare Reforms
  • 4.2 State Citizen-Benefiting Policies
  • 4.3 Requirements of Hospital Upgrading

5. Profile of In-vitro Diagnostic Reagents Registration Control

  • 5.1 Regulatory History in China IVD Market
  • 5.2 Regulatory Status in China IVD Market
    • 5.2.1 Blood Screening Reagents - Drug Administration
    • 5.2.2 Varieties of Blood Screening Reagents
    • 5.2.3 Blood Screening Reagent Test
    • 5.2.4 Nucleic Acid Detection Kits for Blood Screening
    • 5.2.5 Radioactive reagents - Drug Administration
    • 5.2.6 Diagnostic Reagents - Medical Devices Management
  • 5.3 Regulatory Trend in China IVD Market
    • 5.3.1 Blood Screening Reagents Belonging
    • 5.3.2 Quality Improvement
    • 5.3.3 Pre-Evaluation of Registration Standards

6. China IVD Industry Drivers

  • 6.1 Government Efforts to Regulate Laboratory testing
  • 6.2 Increasing Number of Private Hospitals & Independent Testing Laboratories

7. China IVD Industry Challenge

  • 7.1 Lack of Expertise in Advanced Technology in the Local Companies
  • 7.2 Price Pressures Limits the Participation of Multinational IVD Companies in the China IVD Market
  • 7.3 Reimbursement Rates of Different Products are Various in Different Provinces

8. China IVD Market - Company Wise Sales Analysis (2010 - 2018)

  • 8.1 Roche Diagnostic - China IVD Sales & Forecast (2010 - 2018)
  • 8.2 Sysmex Corporation - China IVD Sales & Forecast (2010 - 2018)
  • 8.3 Mindray Medical International Limited - China IVD Sales & Forecast (2010 - 2018)
  • 8.4 Shanghai Kehua Bio-Engineering Co. Ltd. - China IVD Sales & Forecast (2010 - 2018)
  • 8.5 Others - China IVD Sales & Forecast (2010 - 2018)

9. Profiles of Select Private Clinical Labs and Diagnostic Services Companies

  • 9.1 Zhejiang Di'an Diagnostics Technology Co., Ltd.
    • 9.1.1 Company Overview
    • 9.1.2 Products and Services Offered by Di'an
  • 9.2 ADICON Clinical Laboratories (Privately held)
    • 9.2.1 Company Overview
    • 9.2.2 Products and Services Offered by ADICON
  • 9.3 Guangzhou Kingmed Diagnostics Center Co. Ltd.
    • 9.3.1 Company Overview
    • 9.3.2 Products and Services Offered by Kingmed
  • 9.4 Kindstar Global (Privately held)
    • 9.4.1 Company Overview
    • 9.4.2 Products and Services Offered by Kindstar
  • 9.5 BGI-Shenzhen
    • 9.5.1 Company Overview
    • 9.5.2 BGI's Innovative Approach
  • 9.6 OriGene Technologies
    • 9.6.1 Company Overview
    • 9.6.2 Products and Services Offered by OriGene

List of Figure:

  • Figure 2-1: China - IVD Market (Million US$), 2007 - 2013
  • Figure 2-2: China - Forecast for IVD Market (Million US$), 2014 - 2018
  • Figure 2-3: China - IVD Market Share (Percent), 2007 - 2013
  • Figure 2-4: China - Forecast for IVD Market Share (Percent), 2014 - 2018
  • Figure 2-5: China - IVD Market Players Share (Percent), 2010 - 2013
  • Figure 2-6: China - Forecast for IVD Market Players Share (Percent), 2014 - 2018
  • Figure 3-1: China - Clinical Chemistry Market (Million US$), 2007 - 2013
  • Figure 3-2: China - Forecast for Clinical Chemistry Market (Million US$), 2014 - 2018
  • Figure 3-3: China - Immunoassay Market (Million US$), 2007 - 2013
  • Figure 3-4: China - Forecast for Immunoassay Market (Million US$), 2014 - 2018
  • Figure 3-5: China - Hematology Market (Million US$), 2007 - 2013
  • Figure 3-6: China - Forecast for Hematology Market (Million US$), 2014 - 2018
  • Figure 3-7: China - Coagulation Market (Million US$), 2007 - 2013
  • Figure 3-8: China - Forecast for Coagulation Market (Million US$), 2014 - 2018
  • Figure 3-9: China - Microbiology Market (Million US$), 2007 - 2013
  • Figure 3-10: China - Forecast for Microbiology Market (Million US$), 2014 - 2018
  • Figure 3-11: China - Molecular Testing Market (Million US$), 2007 - 2013
  • Figure 3-12: China - Forecast for Molecular Testing Market (Million US$), 2014 - 2018
  • Figure 3-13: China - SMBG Market (Million US$), 2007 - 2013
  • Figure 3-14: China - Forecast for SMBG Market (Million US$), 2014 - 2018
  • Figure 3-15: China - POCT Market (Million US$), 2007 - 2013
  • Figure 3-16: China - Forecast for POCT Market (Million US$), 2014 - 2018
  • Figure 6-1: China - Healthcare Spending (Billion US$), 2011 & 2020
  • Figure 8-1: Roche Diagnostic - China IVD Revenue (Million US$), 2010-2013
  • Figure 8-2: Roche Diagnostic - Forecast for China IVD Revenue (Million US$), 2014-2018
  • Figure 8-3: Sysmex Corporation - China IVD Revenue (Million US$), 2010-2013
  • Figure 8-4: Sysmex Corporation - Forecast for China IVD Revenue (Million US$), 2014-2018
  • Figure 8-5: Mindray Medical - China IVD Revenue (Million US$), 2010-2013
  • Figure 8-6: Mindray Medical - Forecast for China IVD Revenue (Million US$), 2014-2018
  • Figure 8-7: Shanghai Kehua - China IVD Revenue (Million US$), 2010-2013
  • Figure 8-8: Shanghai Kehua - Forecast for China IVD Revenue (Million US$), 2014-2018
  • Figure 8-9: Others - China IVD Revenue (Million US$), 2010-2013
  • Figure 8-10: Others - Forecast for China IVD Revenue (Million US$), 2014-2018
  • Figure 9-1: Kindstar - Collaboration with Hospitals in China (Number), 2006-2012
Back to Top